Insight Molecular Diagnostics (IMDX) Non Operating Income (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Non Operating Income of $123000.0 for Q1 2026, up 124.55% sequentially from -$501000.0 in Q4 2025, and down 3.91% YoY from $128000.0 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Non Operating Income (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 12 years of Non Operating Income data on file, last reported at $123000.0 in Q1 2026.
- Quarterly Non Operating Income fell 3.91% year-over-year to $123000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$55000.0 (down 205.56% YoY) and the FY2025 annual result came in at $4000.0, up 150.0% from the prior year.
- Non Operating Income rose to $123000.0 in Q1 2026 per IMDX's latest filing, from -$501000.0 in the prior quarter.
- The five-year high for Non Operating Income was $278000.0 in Q2 2022, with the low at -$919000.0 in Q4 2022.
- Average Non Operating Income over 5 years is -$43000.0, with a median of $102000.0 recorded in 2024.
- The widest YoY moves for Non Operating Income: up 1637.5% in 2022, down 750.93% in 2022.
- Insight Molecular Diagnostics' Non Operating Income stood at -$919000.0 in 2022, then soared by 116.97% to $156000.0 in 2023, then tumbled by 273.08% to -$270000.0 in 2024, then slumped by 85.56% to -$501000.0 in 2025, then surged by 124.55% to $123000.0 in 2026.
- Business Quant data shows IMDX's Non Operating Income at $123000.0 in Q1 2026, -$501000.0 in Q4 2025, and $223000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 1.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -9.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -73.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 9.60 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 21.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -4.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -52.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 7.33 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | 123,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123,000.00 |
| Dec 31, 2025 | -501,000.00 |
| Sep 30, 2025 | 223,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 128,000.00 |
| Dec 31, 2024 | -270,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 102,000.00 |
| Mar 31, 2024 | 138,000.00 |
| Dec 31, 2023 | 156,000.00 |
| Sep 30, 2023 | 127,000.00 |
| Jun 30, 2023 | -39,000.00 |
| Mar 31, 2023 | 109,000.00 |
| Dec 31, 2022 | -919,000.00 |
| Sep 30, 2022 | -112,000.00 |
| Jun 30, 2022 | 278,000.00 |
| Mar 31, 2022 | -396,000.00 |
| Dec 31, 2021 | -108,000.00 |
| Sep 30, 2021 | -196,000.00 |
| Jun 30, 2021 | 16,000.00 |